
Bridget E. Bunner
Examiner (ID: 13118, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, 1644 |
| Total Applications | 1451 |
| Issued Applications | 718 |
| Pending Applications | 165 |
| Abandoned Applications | 598 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6809119
[patent_doc_number] => 20030199058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/123291
[patent_app_country] => US
[patent_app_date] => 2002-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63528
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123291
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123291 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 14, 2002 | Abandoned |
Array
(
[id] => 6870073
[patent_doc_number] => 20030082762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/123235
[patent_app_country] => US
[patent_app_date] => 2002-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 59755
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123235 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 14, 2002 | Abandoned |
Array
(
[id] => 6809121
[patent_doc_number] => 20030199060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/123771
[patent_app_country] => US
[patent_app_date] => 2002-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63514
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123771 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 14, 2002 | Abandoned |
Array
(
[id] => 508860
[patent_doc_number] => 07195879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-27
[patent_title] => 'Method for identifying modulators of NAv ion channels'
[patent_app_type] => utility
[patent_app_number] => 10/121759
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 9395
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/195/07195879.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121759
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121759 | Method for identifying modulators of NAv ion channels | Apr 11, 2002 | Issued |
Array
(
[id] => 6809114
[patent_doc_number] => 20030199053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/121053
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63514
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199053.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121053
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121053 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 11, 2002 | Abandoned |
Array
(
[id] => 6870071
[patent_doc_number] => 20030082760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/121056
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 59687
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121056 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 11, 2002 | Abandoned |
Array
(
[id] => 6870072
[patent_doc_number] => 20030082761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/121061
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63517
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082761.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121061
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121061 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 11, 2002 | Abandoned |
Array
(
[id] => 931220
[patent_doc_number] => 06979724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-27
[patent_title] => 'Calcium channel proteins'
[patent_app_type] => utility
[patent_app_number] => 10/116949
[patent_app_country] => US
[patent_app_date] => 2002-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 32512
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/979/06979724.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116949 | Calcium channel proteins | Apr 4, 2002 | Issued |
Array
(
[id] => 6651032
[patent_doc_number] => 20030105003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein'
[patent_app_type] => new
[patent_app_number] => 10/115072
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11804
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10115072
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/115072 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein | Apr 3, 2002 | Abandoned |
| 10/089860 | Human inwardly rectifying potassium channel subunit | Apr 2, 2002 | Abandoned |
Array
(
[id] => 6735487
[patent_doc_number] => 20030013122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor'
[patent_app_type] => new
[patent_app_number] => 10/108383
[patent_app_country] => US
[patent_app_date] => 2002-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7001
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108383
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108383 | Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor | Mar 28, 2002 | Abandoned |
Array
(
[id] => 6847742
[patent_doc_number] => 20030166909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'EGF motif protein, EGFL6 materials and methods'
[patent_app_type] => new
[patent_app_number] => 10/112881
[patent_app_country] => US
[patent_app_date] => 2002-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 41223
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166909.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112881
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112881 | EGF motif protein, EGFL6 materials and methods | Mar 28, 2002 | Abandoned |
Array
(
[id] => 5859054
[patent_doc_number] => 20020123106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Novel ABCA9 transporter and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/090454
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 32037
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123106.pdf
[firstpage_image] =>[orig_patent_app_number] => 10090454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/090454 | Novel ABCA9 transporter and uses thereof | Mar 3, 2002 | Abandoned |
| 10/070240 | Novel g protein-coupled receptor protein and dna thereof | Feb 26, 2002 | Abandoned |
Array
(
[id] => 679142
[patent_doc_number] => 07083785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Methods of treatment by administering an anti-BCMA antibody'
[patent_app_type] => utility
[patent_app_number] => 10/077438
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 29
[patent_no_of_words] => 12508
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/083/07083785.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077438
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077438 | Methods of treatment by administering an anti-BCMA antibody | Feb 14, 2002 | Issued |
Array
(
[id] => 7367245
[patent_doc_number] => 20040092445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Use of LP82 to treat hematopoietic disorders'
[patent_app_type] => new
[patent_app_number] => 10/467431
[patent_app_country] => US
[patent_app_date] => 2003-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21489
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467431 | Use of LP82 to treat hematopoietic disorders | Feb 13, 2002 | Issued |
Array
(
[id] => 6562076
[patent_doc_number] => 20020164785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Novel orphan receptors'
[patent_app_type] => new
[patent_app_number] => 10/074901
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5229
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164785.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074901
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074901 | Novel orphan receptors | Feb 11, 2002 | Abandoned |
Array
(
[id] => 968395
[patent_doc_number] => 06939669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Expansion of hematopoietic cells using midkine or pleiotrophin'
[patent_app_type] => utility
[patent_app_number] => 10/071039
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 6193
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939669.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071039
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071039 | Expansion of hematopoietic cells using midkine or pleiotrophin | Feb 7, 2002 | Issued |
Array
(
[id] => 6669387
[patent_doc_number] => 20030114371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM3'
[patent_app_type] => new
[patent_app_number] => 10/071458
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 121646
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114371.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071458 | Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM3 | Feb 6, 2002 | Abandoned |
Array
(
[id] => 6720761
[patent_doc_number] => 20030054449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => '63744, a human sugar transporter family member and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/062960
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38612
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054449.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062960 | 63744, a human sugar transporter family member and uses thereof | Jan 30, 2002 | Abandoned |